ZhuZhou QianJin Pharmaceutical Co.,Ltd

SHSE:600479 Stok Raporu

Piyasa değeri: CN¥4.5b

ZhuZhou QianJin PharmaceuticalLtd Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

ZhuZhou QianJin PharmaceuticalLtd has a total shareholder equity of CN¥3.1B and total debt of CN¥46.8M, which brings its debt-to-equity ratio to 1.5%. Its total assets and total liabilities are CN¥4.5B and CN¥1.4B respectively. ZhuZhou QianJin PharmaceuticalLtd's EBIT is CN¥376.1M making its interest coverage ratio -17.5. It has cash and short-term investments of CN¥1.7B.

Anahtar bilgiler

1.5%

Borç/özkaynak oranı

CN¥46.83m

Borç

Faiz karşılama oranı-9.4x
NakitCN¥1.73b
EşitlikCN¥3.06b
Toplam yükümlülüklerCN¥1.39b
Toplam varlıklarCN¥4.45b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 600479's short term assets (CN¥3.3B) exceed its short term liabilities (CN¥1.3B).

Uzun Vadeli Yükümlülükler: 600479's short term assets (CN¥3.3B) exceed its long term liabilities (CN¥94.2M).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 600479 has more cash than its total debt.

Borcun Azaltılması: 600479's debt to equity ratio has increased from 0.9% to 1.5% over the past 5 years.

Borç Kapsamı: 600479's debt is well covered by operating cash flow (893%).

Faiz Kapsamı: 600479 earns more interest than it pays, so coverage of interest payments is not a concern.


Bilanço


Sağlıklı şirketleri keşfedin